fig2

Albumin-based nanoparticles: a promising strategy to overcome cancer drug resistance

Figure 2. Schematic representation for the preparation of DOX-loaded HSA NPs by desolvation technique, as well as surface functionalization with Transferrin (Tf) and Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)[37]. DOX: doxorubicin; HSA: human serum albumin; NPs: nanoparticles

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/